In certain clinical scenarios, new diagnostic tests such as 14-3-3η protein and multi-biomarker disease activity (MBDA) have been shown to offer ad......READ MORE
expert roundtables by Leonard H. Calabrese, DO; Jeffrey R. Curtis, MD, MS, MPH; and Jonathan Kay, MD
Methotrexate (MTX) and anti–tumor necrosis factor (anti-TNF) agents are therapeutic mainstays in the treatment of rheumatoid arthritis (RA). Howeve......READ MORE
expert roundtables by Leonard H. Calabrese, DO; Jeffrey R. Curtis, MD, MS, MPH; and Jonathan Kay, MD
Risk factors for patients with rheumatoid arthritis (RA) who have an inadequate response (IR) to initial methotrexate (MTX) therapy have been ident......READ MORE
expert roundtables by Leonard H. Calabrese, DO; Jeffrey R. Curtis, MD, MS, MPH; and Jonathan Kay, MD
Corticosteroids are highly effective in the treatment of rheumatoid arthritis (RA) and can rapidly decrease disease activity. The elimination of th......READ MORE
expert roundtables by Leonard H. Calabrese, DO; Jeffrey R. Curtis, MD, MS, MPH; and Jonathan Kay, MD
The standards that constitute an acceptable response to therapy are increasingly high. Combination therapy is often required to achieve goals in pa......READ MORE
patient care perspectives by Jeffrey R. Curtis, MD, MS, MPH
When assessing residual pain in patients with rheumatoid arthritis (RA), it is important to differentiate between symptoms due to RA and symptoms a......READ MORE
